Stonepine Capital Management, LLC - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 28 filers reported holding CARDIOME PHARMA CORP in Q2 2017. The put-call ratio across all filers is 6.65 and the average weighting 0.4%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q1 2018$7,520,000
+51.8%
3,241,550
+1.4%
4.03%
+35.7%
Q4 2017$4,953,000
-18.9%
3,195,692
+11.5%
2.97%
-17.5%
Q3 2017$6,106,000
-15.3%
2,866,785
+79.7%
3.60%
-7.6%
Q2 2017$7,212,000
-13.1%
1,595,549
-42.1%
3.89%
-16.7%
Q1 2017$8,299,000
-4.8%
2,757,260
-12.7%
4.68%
-9.9%
Q4 2016$8,718,000
+45.2%
3,158,816
+64.6%
5.19%
+6.0%
Q3 2016$6,006,0001,918,7224.90%
Other shareholders
CARDIOME PHARMA CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,195,692$4,953,0002.97%
Tamarack Advisers, LP 1,875,000$2,906,0001.59%
CLOUGH CAPITAL PARTNERS L P 2,667,585$4,135,0000.34%
Rock Springs Capital Management LP 1,200,000$1,860,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,678,364$7,251,0000.06%
KNOTT DAVID M 67,978$105,0000.04%
PUTNAM INVESTMENTS LLC 6,184,266$9,586,0000.01%
AlphaOne Investment Services, LLC 10,625$16,0000.01%
A.R.T. Advisors, LLC 34,872$54,0000.00%
Virtu Financial LLC 11,693$18,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders